about
Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.Altered cross-bridge properties in skeletal muscle dystrophiesSlowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration.Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHDMyogenic stem cells: regeneration and cell therapy in human skeletal muscle.CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophyCurrent advances in cell therapy strategies for muscular dystrophies.Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes.In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative studyImmortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders.Age-Associated Methylation Suppresses SPRY1, Leading to a Failure of Re-quiescence and Loss of the Reserve Stem Cell Pool in Elderly Muscle.Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation.Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate.The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies.Myf5 haploinsufficiency reveals distinct cell fate potentials for adult skeletal muscle stem cells.Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy PatientsImmortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in DHeat Shock Treatment Increases Engraftment of Transplanted Human Myoblasts Into Immunodeficient MiceCombined methods to evaluate human cells in muscle xenograftsGlycosaminoglycan mimetic improves enrichment and cell functions of human endothelial progenitor cell colonies
P50
Q34102486-14675AA9-47FB-40BB-ADE9-4132C532E719Q34102486-A196A813-475F-4DF7-BED8-B481236E9F7EQ34335939-68A3AD81-89CA-4A5E-82EA-4A0E07C8D8A2Q35665198-973F4D44-83EA-4129-B6BE-04CC8EC6B5F4Q36295486-D0B9900D-8427-46C6-8021-B6F6940700C7Q36295790-FA47E1F4-9FD5-441D-9DCB-17CD7F914708Q36361347-9E15012D-578F-42BE-AE4B-673C53C5D6E9Q37827157-26867991-7190-4116-85C2-75839BF85A28Q37827157-CC6AD6A8-0AB5-44C4-AFAF-85FB91D116D4Q38269131-04CA7A97-C407-4D68-BB0E-FB96778495B7Q38664815-45CAE0C3-F697-4049-AE12-DCDDDA3C2FE5Q39502175-49D39C94-647D-44CD-A389-1400D174DE6FQ39738924-BBCAB870-734A-4480-A7DC-2CDD0A616009Q40364295-D57C979C-28A8-43B2-B7DE-489B50200392Q41136509-B5A96D59-776B-4376-B71C-D96A83DCA408Q42670912-0FFA53A0-5F6D-41A7-9226-A86C192AB66EQ42934738-95BD785C-2CB3-46BB-BA90-961B0B79B880Q50588974-DF4F278A-2BD1-4499-A994-FE745AD15E44Q57268472-B5A89FCE-9651-4A75-85B1-C602DB56648AQ57268497-C7BE8C83-C41C-4C98-BA22-53788F732FDEQ57268504-549AE2F0-959E-434A-B936-73DBCCAE0251Q64071935-34AF69FA-1F40-4849-ABEA-BBA20CF027A6Q87555932-7AD8979A-F70A-4971-820C-3EC92B78BC9B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elisa Negroni
@ast
Elisa Negroni
@en
Elisa Negroni
@es
Elisa Negroni
@nl
Elisa Negroni
@sl
type
label
Elisa Negroni
@ast
Elisa Negroni
@en
Elisa Negroni
@es
Elisa Negroni
@nl
Elisa Negroni
@sl
prefLabel
Elisa Negroni
@ast
Elisa Negroni
@en
Elisa Negroni
@es
Elisa Negroni
@nl
Elisa Negroni
@sl
P106
P1153
8226916500
P21
P31
P496
0000-0001-8302-2544